Valeant under scrutiny for doubling price of assisted suicide drug sold in U.S.
Friday, March 25, 2016 - 14:30
in Mathematics & Economics
Valeant Pharmaceuticals, accused by U.S. politicians of price-gouging, is facing criticism from assisted-dying advocates across North America for doubling the price of a drug commonly used to hasten death soon after California legalized doctor-assisted suicide.